本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Aligos Therapeutics, Inc.

10.55
-0.5100-4.61%
盘后11.080.5300+5.02%19:28 EDT
成交量:6.12万
成交额:64.55万
市值:6,489.73万
市盈率:-1.11
高:11.19
开:11.06
低:10.07
收:11.06
52周最高:46.80
52周最低:3.76
股本:615.14万
流通股本:300.20万
量比:0.53
换手率:2.04%
股息:- -
股息率:- -
每股收益(TTM):-9.4728
每股收益(LYR):-20.9448
净资产收益率:-87.74%
总资产收益率:-40.30%
市净率:0.64
市盈率(LYR):-0.50

数据加载中...

2025/08/07

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/08/06

重要事件披露

Form 8-K - Current report
2025/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/06/26

重要事件披露

Form 8-K - Current report
2025/05/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/06

重要事件披露

Form 8-K - Current report
2025/04/02

SEC问询函

Form CORRESP - Correspondence
2025/03/10

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/10

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/10

重要事件披露

Form 8-K - Current report
2025/02/12

重要事件披露

Form 8-K - Current report
2025/02/03

重要事件披露

Form 8-K - Current report
2024/11/15

SEC问询函

Form CORRESP - Correspondence
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/06

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans